$ATER
Aterian, Inc.

2021 Q4 Form 10-K Financial Statement

#000156459022010668 Filed on March 16, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $63.32M $247.8M $41.49M
YoY Change 52.62% 33.42% 61.88%
Cost Of Revenue $34.44M $125.9M $22.74M
YoY Change 51.45% 24.71% 37.4%
Gross Profit $28.88M $121.9M $18.75M
YoY Change 54.03% 43.8% 106.5%
Gross Profit Margin 45.61% 49.18% 45.19%
Selling, General & Admin $43.95M $172.5M $23.61M
YoY Change 86.13% 74.85% -0.34%
% of Gross Profit 152.16% 141.53% 125.92%
Research & Development $2.617M $9.837M $1.550M
YoY Change 68.84% 21.0% -47.1%
% of Gross Profit 9.06% 8.07% 8.27%
Depreciation & Amortization $2.569M $200.0K $370.0K
YoY Change 594.32% -33.33% 825.0%
% of Gross Profit 8.9% 0.16% 1.97%
Operating Expenses $32.15M $182.3M $37.89M
YoY Change -15.16% 52.56% 42.34%
Operating Profit -$3.265M -$34.08M -$19.14M
YoY Change -82.94% -1.94% 9.12%
Interest Expense -$778.0K $13.25M -$23.20M
YoY Change -96.65% 163.0% 2174.51%
% of Operating Profit
Other Income/Expense, Net -$2.000K -$45.00K $20.00K
YoY Change -110.0% -266.67% 100.0%
Pretax Income -$6.141M -$235.5M -$44.35M
YoY Change -86.15% 273.33% 139.21%
Income Tax $468.0K $532.0K $0.00
% Of Pretax Income
Net Earnings -$6.609M -$236.0M -$44.35M
YoY Change -85.1% 273.89% 139.08%
Net Earnings / Revenue -10.44% -95.26% -106.89%
Basic Earnings Per Share -$6.67
Diluted Earnings Per Share -$131.2K -$6.671M -$2.116M
COMMON SHARES
Basic Shares Outstanding 35.38M
Diluted Shares Outstanding 35.38M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.32M $30.32M $26.70M
YoY Change 13.55% 13.55% -12.17%
Cash & Equivalents $30.32M $26.72M
Short-Term Investments
Other Short-Term Assets $21.03M $21.03M $11.10M
YoY Change 89.5% 89.5% 105.56%
Inventory $63.05M $63.05M $31.58M
Prepaid Expenses
Receivables $10.48M $10.48M $5.747M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $124.9M $124.9M $75.16M
YoY Change 66.15% 66.06% 2.93%
LONG-TERM ASSETS
Property, Plant & Equipment $1.254M $1.254M $169.0K
YoY Change 642.01% 527.0% -3.43%
Goodwill $119.9M $47.32M
YoY Change 153.48%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.546M $2.546M $3.349M
YoY Change -23.98% -22.85% 1813.71%
Total Long-Term Assets $188.7M $188.7M $82.30M
YoY Change 129.29% 129.28% 5757.37%
TOTAL ASSETS
Total Short-Term Assets $124.9M $124.9M $75.16M
Total Long-Term Assets $188.7M $188.7M $82.30M
Total Assets $313.6M $313.6M $157.5M
YoY Change 99.15% 99.09% 111.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.72M $21.72M $14.86M
YoY Change 46.18% 45.74% -29.47%
Accrued Expenses $17.03M $17.03M $7.800M
YoY Change 118.35% 118.35% 11.43%
Deferred Revenue
YoY Change
Short-Term Debt $40.42M $40.42M $28.40M
YoY Change 42.33% 42.33% 30.88%
Long-Term Debt Due $0.00 $0.00 $21.60M
YoY Change -100.0% -100.0% 620.0%
Total Short-Term Liabilities $83.74M $83.74M $74.73M
YoY Change 12.06% 12.1% 40.41%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $36.50M
YoY Change -100.0% -100.0% 247.62%
Other Long-Term Liabilities $360.0K $5.600M $1.841M
YoY Change -80.45% -75.55% 45925.0%
Total Long-Term Liabilities $360.0K $5.600M $1.841M
YoY Change -80.45% -90.57% 45925.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $83.74M $83.74M $74.73M
Total Long-Term Liabilities $360.0K $5.600M $1.841M
Total Liabilities $89.34M $89.34M $134.1M
YoY Change -33.36% -33.38% 110.48%
SHAREHOLDERS EQUITY
Retained Earnings -$429.0M -$192.9M
YoY Change 122.33% 48.63%
Common Stock $653.7M $216.3M
YoY Change 202.19% 53.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $224.2M $224.2M $23.38M
YoY Change
Total Liabilities & Shareholders Equity $313.6M $313.6M $157.5M
YoY Change 99.15% 99.09% 111.56%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$6.609M -$236.0M -$44.35M
YoY Change -85.1% 273.89% 139.08%
Depreciation, Depletion And Amortization $2.569M $200.0K $370.0K
YoY Change 594.32% -33.33% 825.0%
Cash From Operating Activities -$1.520M -$41.97M -$1.510M
YoY Change 0.66% -789.03% -87.47%
INVESTING ACTIVITIES
Capital Expenditures -$18.00K $32.00K -$24.98M
YoY Change -99.93% -64.04% -2501.92%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$10.58M
YoY Change
Cash From Investing Activities -$18.00K -$44.91M -$24.98M
YoY Change -99.93% 14.98% 19115.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 297.0K 95.57M 18.82M
YoY Change -98.42% 195.71% 174.34%
NET CHANGE
Cash From Operating Activities -1.520M -41.97M -1.510M
Cash From Investing Activities -18.00K -44.91M -24.98M
Cash From Financing Activities 297.0K 95.57M 18.82M
Net Change In Cash -1.241M 8.695M -7.670M
YoY Change -83.82% -1356.5% 44.17%
FREE CASH FLOW
Cash From Operating Activities -$1.520M -$41.97M -$1.510M
Capital Expenditures -$18.00K $32.00K -$24.98M
Free Cash Flow -$1.502M -$42.00M $23.47M
YoY Change -106.4% -799.78% -279.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3027361
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114451000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
185704000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
247767000
CY2019 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
167146000
CY2020 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
387277000
CY2021 ater Proceeds From Insurance Financing Activities
ProceedsFromInsuranceFinancingActivities
2424000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-58789000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
29447000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34681000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000
CY2022Q1 ater Operating Lease Liability Current Statements Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementsOfFinancialPositionExtensibleList
AccruedExpensesAndOtherLiabilitiesCurrent
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
5369000
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
204000
CY2020 ater Adjustments To Additional Paid In Capital Shares Of Restricted Common Stock Retired In Connection With Vesting
AdjustmentsToAdditionalPaidInCapitalSharesOfRestrictedCommonStockRetiredInConnectionWithVesting
-150000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21770000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
44000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-236024000
CY2020Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
330000
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
4449000
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
137000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
338000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
471000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5800000
CY2020Q4 ater Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
8340000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10661000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33506000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30631000
CY2019 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4386000
CY2021 ater Stock Issued During Period Value Common Stock Upon Exercise Of Stock Option Grants
StockIssuedDuringPeriodValueCommonStockUponExerciseOfStockOptionGrants
9033000
CY2021 ater Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
40318000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M15D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M7D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M7D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y9M7D
CY2021 dei Auditor Firm
AuditorFirmId
34
CY2021 dei Auditor Name
AuditorName
Deloitte & Touche LLP
CY2021 dei Auditor Location
AuditorLocation
New York, NY
CY2020Q4 us-gaap Cash
Cash
26718000
CY2021Q4 us-gaap Cash
Cash
30317000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5747000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10478000
CY2020Q4 us-gaap Inventory Net
InventoryNet
31582000
CY2021Q4 us-gaap Inventory Net
InventoryNet
63045000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11111000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21034000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
75158000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
124874000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
169000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1254000
CY2020Q4 us-gaap Goodwill
Goodwill
47318000
CY2021Q4 us-gaap Goodwill
Goodwill
119941000
CY2020Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
31460000
CY2021Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
64955000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3349000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2546000
CY2020Q4 us-gaap Assets
Assets
157454000
CY2021Q4 us-gaap Assets
Assets
313570000
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
12190000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-45000
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
32845000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14856000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
21716000
CY2020Q4 us-gaap Loans Payable Current
LoansPayableCurrent
21600000
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
16231000
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
7577000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1515000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
3983000
CY2020Q4 ater Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
8340000
CY2021Q4 ater Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
17621000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
74732000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
83742000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1841000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
360000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
21016000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5240000
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
36483000
CY2020Q4 us-gaap Liabilities
Liabilities
134072000
CY2021Q4 us-gaap Liabilities
Liabilities
89342000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27074791
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55090237
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
5000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
216305000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
653650000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-192935000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-428959000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-468000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
23382000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
224228000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
157454000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
313570000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114451000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
185704000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
247767000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
69411000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
100958000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
125904000
CY2019 us-gaap Gross Profit
GrossProfit
45040000
CY2020 us-gaap Gross Profit
GrossProfit
84746000
CY2021 us-gaap Gross Profit
GrossProfit
121863000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
55206000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
68005000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
127369000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8130000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9837000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45099000
CY2021 ater Settlement Charge Of Contingent Earnout Liability
SettlementChargeOfContingentEarnoutLiability
4164000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4554000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-18659000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19303000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1004000
CY2019 ater Increase Decrease In Accounts Payable Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedAndOtherLiabilities
3334000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21770000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
44000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-48000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
23382000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-236024000
CY2021 ater Stock Issued During Period Value Common Stock Upon Exercise Of Stock Option Grants
StockIssuedDuringPeriodValueCommonStockUponExerciseOfStockOptionGrants
9033000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-30529000
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3254000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2037000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-138859000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
21338000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
26455000
CY2021 ater Loss On Initial Issuance Of Warrant
LossOnInitialIssuanceOfWarrant
20147000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-41000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58760000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-63078000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-235492000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
532000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-58789000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-63126000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-236024000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.35
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.68
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.67
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13516844
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17167999
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35379005
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
17000
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-48000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-477000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-48000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-477000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58772000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-63174000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-236501000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
5369000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-58789000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
29447000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34681000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
10727000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-63126000
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
204000
CY2020 ater Adjustments To Additional Paid In Capital Shares Of Restricted Common Stock Retired In Connection With Vesting
AdjustmentsToAdditionalPaidInCapitalSharesOfRestrictedCommonStockRetiredInConnectionWithVesting
-150000
CY2021 ater Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
40318000
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
47369000
CY2021 ater Issuance Of Restricted Stock Awards
IssuanceOfRestrictedStockAwards
7669000
CY2021 ater Issuance Of Warrants To High Trail Value
IssuanceOfWarrantsToHighTrailValue
39016000
CY2021 ater Issuance Of Warrants To Midcap
IssuanceOfWarrantsToMidcap
589000
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
97088000
CY2021 ater Reclassification Of Warrants To Liability
ReclassificationOfWarrantsToLiability
-21260000
CY2021 ater Fair Value Of Warrant Modification On Extinguishment
FairValueOfWarrantModificationOnExtinguishment
17399000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
36735000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22696000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-477000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
224228000
CY2019 us-gaap Profit Loss
ProfitLoss
-58789000
CY2020 us-gaap Profit Loss
ProfitLoss
-63126000
CY2021 us-gaap Profit Loss
ProfitLoss
-236024000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
183000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
552000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7326000
CY2019 ater Provision For Sales Returns
ProvisionForSalesReturns
134000
CY2020 ater Provision For Sales Returns
ProvisionForSalesReturns
92000
CY2021 ater Provision For Sales Returns
ProvisionForSalesReturns
43000
CY2019 ater Amortization Of Deferred Financing Costs And Debt Discounts
AmortizationOfDeferredFinancingCostsAndDebtDiscounts
1218000
CY2020 ater Amortization Of Deferred Financing Costs And Debt Discounts
AmortizationOfDeferredFinancingCostsAndDebtDiscounts
2245000
CY2021 ater Amortization Of Deferred Financing Costs And Debt Discounts
AmortizationOfDeferredFinancingCostsAndDebtDiscounts
7742000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
34681000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
22716000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
28987000
CY2020 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
12731000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-30529000
CY2021 ater Gain Loss In Connection With Settlement Of Earnout
GainLossInConnectionWithSettlementOfEarnout
-4164000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
21338000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
26455000
CY2021 ater Loss On Initial Issuance Of Warrant
LossOnInitialIssuanceOfWarrant
20147000
CY2021 ater Provision For Barter Credits
ProvisionForBarterCredits
1000000
CY2021 ater Loss From Derivative Liability Discount Related To Term Loan
LossFromDerivativeLiabilityDiscountRelatedToTermLoan
3254000
CY2019 ater Allowance For Doubtful Accounts And Other
AllowanceForDoubtfulAccountsAndOther
94000
CY2021 ater Allowance For Doubtful Accounts And Other
AllowanceForDoubtfulAccountsAndOther
4200000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-309000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4703000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5360000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1513000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7856000
CY2020 ater Increase Decrease In Accounts Payable Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedAndOtherLiabilities
-6991000
CY2021 ater Increase Decrease In Accounts Payable Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedAndOtherLiabilities
14120000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25200000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6091000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41969000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
114000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
89000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32000
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
6000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1284000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39054000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44905000
CY2019 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
36000000
CY2019 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
5446000
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
9085000
CY2021 ater Proceeds From Cancellation Of Warrant
ProceedsFromCancellationOfWarrant
16957000
CY2020 ater Proceeds From Issuance Of Common Stock Follow On Public Offering Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockFollowOnPublicOfferingNetOfIssuanceCosts
23416000
CY2021 ater Proceeds From Issuance Of Common Stock Follow On Public Offering Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockFollowOnPublicOfferingNetOfIssuanceCosts
36735000
CY2021 ater Proceeds From Payments For Stock Options Exercised
ProceedsFromPaymentsForStockOptionsExercised
9033000
CY2021 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7971000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
44000
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
150000
CY2019 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
98663000
CY2020 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
123633000
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
48750000
CY2019 ater Proceeds From Insurance Financing Activities
ProceedsFromInsuranceFinancingActivities
3833000
CY2020 ater Proceeds From Insurance Financing Activities
ProceedsFromInsuranceFinancingActivities
2660000
CY2020 ater Non Cash Consideration Paid To Contractors
NonCashConsiderationPaidToContractors
1672000
CY2020 ater Debt Original Issue Discount
DebtOriginalIssueDiscount
5000000
CY2020 ater Discount Of Debt Relating To Warrants Issuance
DiscountOfDebtRelatingToWarrantsIssuance
10483000
CY2019 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
195000
CY2019 ater Payments Of Insurance Obligation Financing Activities
PaymentsOfInsuranceObligationFinancingActivities
2783000
CY2020 ater Payments Of Insurance Obligation Financing Activities
PaymentsOfInsuranceObligationFinancingActivities
3066000
CY2021 ater Payments Of Insurance Obligation Financing Activities
PaymentsOfInsuranceObligationFinancingActivities
3048000
CY2019 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
55000
CY2020 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
32000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36566000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32319000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
95569000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-48000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10081000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30097000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
38315000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30353000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26718000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30317000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
307000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3250000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7849000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
129000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
129000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
149000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30789000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30097000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
38315000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
3201000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
2787000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
5611000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
21000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
46000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
41000
CY2020 ater Non Cash Barter Exchange Of Inventory For Advertising Logistics Credits
NonCashBarterExchangeOfInventoryForAdvertisingLogisticsCredits
3352000
CY2021 ater Modification Of Warrants Between Equity And Liability
ModificationOfWarrantsBetweenEquityAndLiability
75828000
CY2021 ater Non Cash Consideration Paid To Contractors
NonCashConsiderationPaidToContractors
7289000
CY2019 ater Equity Fundraising Costs Not Paid
EquityFundraisingCostsNotPaid
160000
CY2020 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
142000
CY2021 ater Debt Original Issue Discount
DebtOriginalIssueDiscount
2475000
CY2020 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
18073000
CY2020 ater Issuance Of Common Stock In Connection With Acquisitions
IssuanceOfCommonStockInConnectionWithAcquisitions
29075000
CY2020 ater Non Cash Fair Value Of Contingent Considerations
NonCashFairValueOfContingentConsiderations
9800000
CY2021 ater Non Cash Fair Value Of Contingent Considerations
NonCashFairValueOfContingentConsiderations
20971000
CY2021 ater Discount Of Debt Relating To Warrants Issuance
DiscountOfDebtRelatingToWarrantsIssuance
51284000
CY2021 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
16550000
CY2021 ater Issuance Of Common Stock In Connection With Acquisition
IssuanceOfCommonStockInConnectionWithAcquisition
50529000
CY2021 us-gaap Stock Issued1
StockIssued1
125562000
CY2021 ater Issuance Of Common Stock Healing Solutions Earnout Settlement
IssuanceOfCommonStockHealingSolutionsEarnoutSettlement
7914000
CY2021Q4 ater Substantial Doubt About Going Concern Cash And Cash Equivalents
SubstantialDoubtAboutGoingConcernCashAndCashEquivalents
30300000
CY2021Q4 ater Substantial Doubt About Going Concern Accumulated Deficit
SubstantialDoubtAboutGoingConcernAccumulatedDeficit
429000000.0
CY2021 ater Substantial Doubt About Going Concern Net Loss
SubstantialDoubtAboutGoingConcernNetLoss
236000000.0
CY2021 ater Substantial Doubt About Going Concern Net Cash Used In Operating Activities
SubstantialDoubtAboutGoingConcernNetCashUsedInOperatingActivities
42000000.0
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates<span style="font-weight:normal;">—</span><span style="color:#000000;font-weight:normal;">Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period covered by the financial statements and accompanying notes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from those estimates.</span></p>
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk<span style="font-weight:normal;">—Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and accounts receivable. The Company maintains cash and restricted cash with various domestic and foreign financial institutions of high credit quality. The Company performs periodic evaluations of the relative credit standing of all of the aforementioned institutions. </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s accounts receivables are derived from sales contracts with a large number of customers. The Company maintains reserves for potential credit losses on customer accounts when deemed necessary. Significant customers are those which represent more than 10% of the Company’s total net revenue or gross accounts receivable balance at the balance sheet date. During the years-ended December 31, 2020 and 2021, the Company had no one customer that accounted for 10% or more of total net revenue. In addition, as of December 31, 2020 and 2021, the Company has no one customer that accounted for 10% or more of gross accounts receivable. As of December 31, 2020 and 2021, approximately 68% and 42%, respectively, of its accounts receivable is held by the Company’s sales platform vendor, Amazon, which collects money on the Company’s behalf from its customers.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s business is reliant on one key vendor which currently provides the Company with its sales platform, logistics and fulfillment operations, including certain warehousing for the Company’s net goods, and invoicing and collection of its revenue from the Company’s end customers. In 2020, approximately 88% of the Company’s revenue was through or with the Amazon sales platform and in 2021, 93% of its net revenue was through or with the Amazon sales platform.</p>
CY2021 ater Income Tax Benefit Recognition Criteria Percentage Threshold
IncomeTaxBenefitRecognitionCriteriaPercentageThreshold
0.50
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114451000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
185704000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
247767000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114451000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
185704000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
247767000
CY2021 us-gaap Goodwill Impaired Facts And Circumstances Leading To Impairment
GoodwillImpairedFactsAndCircumstancesLeadingToImpairment
The Company performed a full step one impairment test at December 31, 2021 and concluded no impairment and that its estimated fair-values exceeded its carrying values by 21% as of the year-ended December 31, 2021.
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q4 us-gaap Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount
ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
0.21
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
22753000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
48079000
CY2020Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
8829000
CY2021Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
14966000
CY2020Q4 us-gaap Inventory Net
InventoryNet
31582000
CY2021Q4 us-gaap Inventory Net
InventoryNet
63045000
CY2020Q4 us-gaap Other Inventory Warehouse
OtherInventoryWarehouse
5300000
CY2021Q4 us-gaap Other Inventory Warehouse
OtherInventoryWarehouse
8400000
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5747000
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
10478000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5747000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10478000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
760000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1813000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
591000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
559000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
169000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1254000
CY2019 us-gaap Depreciation
Depreciation
200000
CY2020 us-gaap Depreciation
Depreciation
300000
CY2021 us-gaap Depreciation
Depreciation
200000
CY2021Q4 ater Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
17621000
CY2020Q4 ater Prepaid Inventory
PrepaidInventory
4361000
CY2021Q4 ater Prepaid Inventory
PrepaidInventory
4137000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
3250000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
7998000
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1504000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2440000
CY2020Q4 ater Consulting Fees
ConsultingFees
738000
CY2021Q4 ater Consulting Fees
ConsultingFees
2263000
CY2021Q4 ater Amazon Global Logistics
AmazonGlobalLogistics
2865000
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1258000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1331000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11111000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21034000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
293000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
162000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
483000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
331000
CY2020Q4 ater Accrued Logistics Costs Current
AccruedLogisticsCostsCurrent
1068000
CY2021Q4 ater Accrued Logistics Costs Current
AccruedLogisticsCostsCurrent
578000
CY2020Q4 ater Product Related Accruals
ProductRelatedAccruals
3221000
CY2021Q4 ater Product Related Accruals
ProductRelatedAccruals
2984000
CY2020Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
457000
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
678000
CY2020Q4 ater Sales Return Reserve
SalesReturnReserve
547000
CY2021Q4 ater Sales Return Reserve
SalesReturnReserve
590000
CY2020Q4 ater Accrued Fulfillment Expense
AccruedFulfillmentExpense
381000
CY2021Q4 ater Accrued Fulfillment Expense
AccruedFulfillmentExpense
744000
CY2020Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
952000
CY2021Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
967000
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
25971000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
522905
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.25
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
25971000
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y2M1D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
21000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
28000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
72000
CY2020 ater Line Of Credit Facility And Term Loan Interest Expense
LineOfCreditFacilityAndTermLoanInterestExpense
1900000
CY2021 ater Line Of Credit Facility And Term Loan Interest Expense
LineOfCreditFacilityAndTermLoanInterestExpense
400000
CY2020 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
700000
CY2021 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
100000
CY2021Q3 us-gaap Accounts Receivable Sale
AccountsReceivableSale
65000000.0
CY2021Q2 ater Warrants Prior To Day
WarrantsPriorToDay
60 days
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2666667
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-138900000
CY2019 us-gaap Interest Expense
InterestExpense
4532000
CY2020 us-gaap Interest Expense
InterestExpense
5038000
CY2021 us-gaap Interest Expense
InterestExpense
13250000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
146000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
59000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
595000
CY2019 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4386000
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4979000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-12655000
CY2021 us-gaap Common Stock Voting Rights
CommonStockVotingRights
The Company has one class of common shares issued and available. Each share of common stock has the right to one vote per share
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1570728
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.09
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
12756000
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1011422
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.00
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
36401
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.17
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
522905
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.25
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
25971000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
520256
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.25
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
8000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
265000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
29000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
28000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
337000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
532000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34681000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22716000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28987000
CY2020Q4 us-gaap Purchase Obligation
PurchaseObligation
55000000.0
CY2021Q4 us-gaap Purchase Obligation
PurchaseObligation
32300000
CY2020Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
500000
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
700000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-58718000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-62985000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-233846000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-42000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-93000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1646000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58760000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-63078000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-235492000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
253000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
20000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
32000
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-90000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
20000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
195000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-12339000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-13246000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-49454000
CY2019 ater Income Tax Rate Reconciliation Permanent Differences
IncomeTaxRateReconciliationPermanentDifferences
325000
CY2020 ater Income Tax Rate Reconciliation Permanent Differences
IncomeTaxRateReconciliationPermanentDifferences
6434000
CY2021 ater Income Tax Rate Reconciliation Permanent Differences
IncomeTaxRateReconciliationPermanentDifferences
3000
CY2021 ater Income Tax Rate Reconciliation Debt Extinguishment
IncomeTaxRateReconciliationDebtExtinguishment
33746000
CY2021 ater Income Tax Rate Reconciliation Warrant Liabilities
IncomeTaxRateReconciliationWarrantLiabilities
11066000
CY2021 ater Income Tax Rate Reconciliation Stock Compensation
IncomeTaxRateReconciliationStockCompensation
10602000
CY2021 ater Income Tax Rate Reconciliation Change In Fair Value Contingent Consideration
IncomeTaxRateReconciliationChangeInFairValueContingentConsideration
-3143000
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-4000
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-4000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-44000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2034000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2056000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-6424000
CY2019 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
45000
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
313000
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
264000
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-5577000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
14036000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
8607000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9493000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
532000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0008
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0023
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
133000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
130000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
21070000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
36250000
CY2020Q4 ater Deferred Tax Assets Stock Options
DeferredTaxAssetsStockOptions
12336000
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1528000
CY2021Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
3562000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
560000
CY2021Q4 ater Deferred Tax Liabilities Contingent Consideration
DeferredTaxLiabilitiesContingentConsideration
1084000
CY2021Q4 ater Deferred Tax Assets Stock Options
DeferredTaxAssetsStockOptions
3592000
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
14000
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
15000
CY2020Q4 ater Deferred Tax Assets Tax Deferred Expense Interest Expense Limitation
DeferredTaxAssetsTaxDeferredExpenseInterestExpenseLimitation
2392000
CY2021Q4 ater Deferred Tax Assets Tax Deferred Expense Interest Expense Limitation
DeferredTaxAssetsTaxDeferredExpenseInterestExpenseLimitation
10151000
CY2020Q4 ater Deferred Tax Assets Intangibles
DeferredTaxAssetsIntangibles
58000
CY2021Q4 ater Deferred Tax Assets Intangibles
DeferredTaxAssetsIntangibles
0
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1917000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2364000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
37823000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
47316000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
97000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5186000
CY2020Q4 ater Deferred Tax Assets Fixed Assets
DeferredTaxAssetsFixedAssets
14000
CY2021Q4 ater Deferred Tax Assets Fixed Assets
DeferredTaxAssetsFixedAssets
18000
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
103000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
130000
CY2020Q4 ater Deferred Tax Liabilities Net Of Valuation Allowance
DeferredTaxLiabilitiesNetOfValuationAllowance
117000
CY2021Q4 ater Deferred Tax Liabilities Net Of Valuation Allowance
DeferredTaxLiabilitiesNetOfValuationAllowance
6882000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
20000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1696000
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
87000000.0
CY2020 ater Operating Loss Carry Forward Expiration Year
OperatingLossCarryForwardExpirationYear
2034
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
152000000.0
CY2021 ater Operating Loss Carry Forward Expiration Year
OperatingLossCarryForwardExpirationYear
2034
CY2021 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
The Company’s ability to utilize its NOL carryforwards may be limited pursuant to Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), if the Company has had a change in ownership of more than 50% of its capital stock over a three-year period pursuant to Section 382 of the Code. These complex changes of ownership rules generally focus on ownership changes involving stockholders owning directly or indirectly 5% or more of a company’s stock, including certain public “groups” of stockholders as set forth by Section 382 of the Code, including those arising from new stock issuances and other equity transactions.
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-58789000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-63126000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-236024000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13516844
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17167999
CY2021 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
264725000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-54333000
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35379005
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.35
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.68
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.67
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3595078
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4975759
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-34751000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-34077000
CY2019 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
-46244000
CY2020 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
639000
CY2021 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
-30771000
CY2020Q4 ater Acquisition Date Fair Value Of Contingent Earn Out Liabilities
AcquisitionDateFairValueOfContingentEarnOutLiabilities
9800000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
22531000
CY2021 ater Acquisition Date Fair Value Of Contingent Earn Out Liabilities And Inventory To Be Settled In Shares
AcquisitionDateFairValueOfContingentEarnOutLiabilitiesAndInventoryToBeSettledInShares
20971000
CY2021 ater Business Combination Contingent Consideration Change In Fair Value Of Contingent Earn Out Liabilities
BusinessCombinationContingentConsiderationChangeInFairValueOfContingentEarnOutLiabilities
-30529000
CY2021 ater Contingent Consideration Earn Out Payments
ContingentConsiderationEarnOutPayments
3750000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
9223000
CY2021Q4 ater Contingent Consideration Earn Out Payments
ContingentConsiderationEarnOutPayments
3800000
CY2021Q4 ater Common Stock Earn Out Payments
CommonStockEarnOutPayments
1400000
CY2021 ater Settlement Charge Of Contingent Earnout Liability
SettlementChargeOfContingentEarnoutLiability
4200000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
333000
CY2020 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
31611000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
31944000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
484000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
31460000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
31944000
CY2021 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
40500000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
72444000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7489000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
64955000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
7228000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
7214000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
7171000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
7130000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
7130000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
29082000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
64955000

Files In Submission

Name View Source Status
0001564590-22-010668-index-headers.html Edgar Link pending
0001564590-22-010668-index.html Edgar Link pending
0001564590-22-010668.txt Edgar Link pending
0001564590-22-010668-xbrl.zip Edgar Link pending
ater-10k_20211231.htm Edgar Link pending
ater-10k_20211231_htm.xml Edgar Link completed
ater-20211231.xsd Edgar Link pending
ater-20211231_cal.xml Edgar Link unprocessable
ater-20211231_def.xml Edgar Link unprocessable
ater-20211231_lab.xml Edgar Link unprocessable
ater-20211231_pre.xml Edgar Link unprocessable
ater-ex211_9.htm Edgar Link pending
ater-ex231_10.htm Edgar Link pending
ater-ex311_7.htm Edgar Link pending
ater-ex312_11.htm Edgar Link pending
ater-ex321_6.htm Edgar Link pending
ater-ex49_420.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gx1bvbxp4mky000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending